Search
for
Sort by
Research 301–330 of 1000+
- Immunosenescence and inflammaging in Parkinson’s disease: mechanisms and therapeutic prospects
- Abstract 152
- Skin disorders in Parkinson’s disease: potential biomarkers and risk factors
- Is seborrhea a sign of autonomic impairment in Parkinson's disease?
- A regulatory perspective on pharmacokinetic/pharmacodynamic modelling
- Hair glucocorticoid levels in Parkinson’s disease
- Are finasteride-related penile curvature/Peyronie’s disease Adverse Event Reports worthy of further clinical investigation? Disproportionality analysis based on both the Food and Drug Administration (FDA) and the European Medicines Agency (EMA) pharmacovigilance databases
- Home intense pulsed light (IPL) device is a useful tool to decrease hair burden in pilonidal patients – a case series
- Bioinformatic network analysis on the molecular interactions between Parkinson’s disease, alpha-synuclein, and infertility condition
- LB1682 Association of inflammatory and pigmentary disorders with alcohol use disorder and psychiatric illness
- Tackling underrepresentation to aid understanding of Parkinson’s disease: Progress and further opportunities
- Pembrolizumab-Induced Autoimmune Hepatitis
- Tackling underrepresentation to aid understanding of Parkinson’s disease: Progress and further opportunities
- Fluoride Tooth Paste: A Cause of Perioral Dermatitis
- Palladium nanoparticles on a pyridinium supported ionic liquid phase: a recyclable and low-leaching palladium catalyst for aminocarbonylation reactions
- IGFBP5 Promotes Neuronal Apoptosis in a 6-OHDA-Toxicant Model of Parkinson’s Disease by Inhibiting the Sonic Hedgehog Signaling Pathway
- PINK1 deficiency rewires early immune responses in a mouse model of Parkinson’s disease triggered by intestinal infection
- Novel associations of VPS13C with phenotype and conversion of idiopathic REM sleep behavior disorder
- Do Dermatoses Trigger Neurodegenerative Diseases? A Retrospective Observational Study
- Effets de médicaments gonadiques pour la neuroprotection du cerveau chez un modèle animal de la maladie de Parkinson
- Kin‐cohort analysis of <i>LRRK2</i>‐G2019S penetrance in Parkinson's disease
- Finasteride Attenuates Pathological Gambling in Patients With Parkinson Disease
- Neuroactive gonadal drugs for neuroprotection in male and female models of Parkinson's disease
- Effect of the 5α-reductase enzyme inhibitor dutasteride in the brain of intact and parkinsonian mice
- SARS-CoV-2 Infection and Alpha-Synucleinopathies: Potential Links and Underlying Mechanisms
- Three-Dimensional Analysis of Sex- and Gonadal Status- Dependent Microglial Activation in a Mouse Model of Parkinson’s Disease
- Role of the SOX family in cancer immune evasion: Emerging player and promising therapeutic opportunities
- A case of bullous pemphigoid in a malignant melanoma patient following an increased Th2/Th1 ratio in peripheral blood cells after nivolumab treatment
- Peripheral Neuroprotective and Immunomodulatory Effects of 5α-Reductase Inhibitors in Parkinson’s Disease Models
- Pyodermatitis vegetans associated with multiple myeloma